A powerful new strategy for analyzing the clonal origin of human cell populations has been developed. This strategy involves the use of recombinant DNA probes that simultaneously detect restriction fragment length polymorphisms and methylation patterns of X-chromosome genes. Our long term goals are to use this strategy to study specific central issues in neoplasia and X-linked diseases predisposing to neoplasia. The immediate goals are to continue our studies in the following areas: I. EXTENSIONOF CLONAL ANALYSIS Additional genes from the active X-chromosome will be cloned to increase the number of polymorphic markers that can be used for clonal analysis. This will allow the study of virtually any female. II. ANALYSIS OF SPECIFIC DISEASES 1. Colonic neoplasms. The clonal origin of colonic adenomas and carcinomas will be defined to determine whether these neoplasms are derived from one or many precursor cells. 2. Transitional cell carcinomas of the bladder. Investigations will be performed to determine whether the multiple bladder lesions found in patients with this disease are derived from one transformation event with subsequent intravesicular spread or multiple independent transformation events. 3. Leukemias. Our studies have shown that acute nonlymphocytic leukemia cells differentiate to form mature granulocytes both during active disease and during remission. Studies are proposed to define the incidence of this differentiation, determine whether specific genetic changes are compatible with differentiation, and elucidate correlations between the capacity to differentiate and various clinical parameters. 4. X-linked diseases predisposing to neoplasia. Clonal analysis has the capacity to identify female carriers of certain X-linked diseases associated with neoplasia. The feasibility of using such analyses to provide genetic counselling to families with these diseases will be explored.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Method to Extend Research in Time (MERIT) Award (R37)
Project #
Application #
Study Section
Chemical Pathology Study Section (CPA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Johns Hopkins University
Schools of Medicine
United States
Zip Code
He, T C; Zhou, S; da Costa, L T et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95:2509-14
Nicolaides, N C; Littman, S J; Modrich, P et al. (1998) A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Mol Cell Biol 18:1635-41
Lengauer, C; Kinzler, K W; Vogelstein, B (1997) DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A 94:2545-50
Velculescu, V E; Zhang, L; Zhou, W et al. (1997) Characterization of the yeast transcriptome. Cell 88:243-51
Da Costa, L T; Jen, J; He, T C et al. (1996) Converting cancer genes into killer genes. Proc Natl Acad Sci U S A 93:4192-6
Thiagalingam, S; Lisitsyn, N A; Hamaguchi, M et al. (1996) Evaluation of the FHIT gene in colorectal cancers. Cancer Res 56:2936-9
Thiagalingam, S; Lengauer, C; Leach, F S et al. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343-6
Liu, B; Parsons, R; Papadopoulos, N et al. (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2:169-74
Huang, J; Papadopoulos, N; McKinley, A J et al. (1996) APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A 93:9049-54
Polyak, K; Waldman, T; He, T C et al. (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10:1945-52

Showing the most recent 10 out of 71 publications